From AI-driven vaccine candidate selection to the mass roll-out of virtual consultations, digital transformation is accelerating at an unprecedented rate in the face of COVID-19.
Researchers in the UK have started testing a coronavirus test that would do away with the need to swab the nose and throat, and instead use a saliva sample that could be easily
Efforts to get Gilead’s experimental COVID-19 drug remdesivir to patients in badly-hit India are building after drug maker Cipla announced it had launched the drug in the country.
Two eye-catching research projects involving drugs from Roche have produced disappointing trial results, after its prostate cancer drug achieved only one of its targets and its inflammatory
A UK research group has been given £2.2 million in funding to seek out additional drugs to treat COVID-19, in case the first wave of therapies fail to show a benefit.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.